WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-treated Metastatic Colorectal Cancer Patients

被引：0
|
作者：
Bosch, L. J. W. [1 ]
Luo, Y. [2 ]
Lao, V. V. [3 ]
Snaebjornsson, P. [1 ]
Trooskens, G. [4 ]
Vlassenbroeck, I. [5 ]
Mongera, S. [1 ]
Tang, W. [3 ]
Welcsh, P. [3 ]
Herman, J. [6 ]
Koopman, M. [7 ]
Nagtegaal, I. [8 ]
Punt, C. J. A. [9 ]
van Criekinge, W. [4 ]
Meijer, G. A. [1 ]
Monnat, R. J. [3 ]
Carvalho, B. [1 ]
Grady, W. M. [3 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Ghent, B-9000 Ghent, Belgium
[5] MDxHealth SA, Liege, Belgium
[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[7] Univ Med Ctr Utrecht, Nijmegen, Netherlands
[8] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[9] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF PATHOLOGY | 2015年 / 237卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Grothey, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 22 - 23
  • [32] Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer
    Kemeny, N
    Tong, W
    Gonen, M
    Stockman, J
    Di Lauro, C
    Teitcher, J
    White, P
    Price, C
    Saltz, L
    Sharma, S
    Graham, MA
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1490 - 1496
  • [33] Clinical predictors of severe toxicity in patients treated with combination chemotherapy with irinotecan and/or oxaliplatin for metastatic colorectal cancer
    Diaz, Roberto
    Aparicio, Jorge
    Molina, Jorge
    Palomar, Laura
    Gimenez, Alejandra
    Ponce, Jose
    Segura, Angel
    Gomez-Codina, Jose
    MEDICAL ONCOLOGY, 2006, 23 (03) : 347 - 357
  • [34] Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer
    Shitara, Kohei
    Ura, Takashi
    Matsuo, Keitaro
    Takahari, Daisuke
    Yokota, Tomoya
    Yuki, Satoshi
    Yoshida, Motoki
    Utsunomiya, Setsuo
    Sato, Yozo
    Yamaura, Hidekazu
    Kato, Mina
    Inaba, Yoshitaka
    Tajika, Masahiro
    Kawai, Hiroki
    Yamazaki, Kentaro
    Komatsu, Yoshito
    Muro, Kei
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (18) : 2673 - 2680
  • [35] CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
    Kim, Se Hyun
    Park, Kyu Hyun
    Shin, Sang Joon
    Lee, Kang Young
    Kim, Tae Il
    Kim, Nam Kyu
    Rha, Sun Young
    Ahn, Joong Bae
    YONSEI MEDICAL JOURNAL, 2018, 59 (05) : 588 - 594
  • [36] CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
    Chen, Kuo-Hsing
    Lin, Liang-In
    Tseng, Li-Hui
    Lin, Yu-Lin
    Liau, Jau-Yu
    Tsai, Jia-Huei
    Liang, Jin-Tung
    Lin, Been-Ren
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    ONCOLOGY, 2019, 96 (03) : 156 - 163
  • [37] Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer
    Hiroyuki Arai
    Yi Xiao
    Joshua Millstein
    Jingyuan Wang
    Francesca Battaglin
    Natsuko Kawanishi
    Priya Jayachandran
    Shivani Soni
    Wu Zhang
    Christoph Mancao
    Bodour Salhia
    Shannon M. Mumenthaler
    Aparna R. Parikh
    Heinz-Josef Lenz
    British Journal of Cancer, 2022, 126 : 72 - 78
  • [38] Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer
    Arai, Hiroyuki
    Xiao, Yi
    Millstein, Joshua
    Wang, Jingyuan
    Battaglin, Francesca
    Kawanishi, Natsuko
    Jayachandran, Priya
    Soni, Shivani
    Zhang, Wu
    Mancao, Christoph
    Salhia, Bodour
    Mumenthaler, Shannon M.
    Parikh, Aparna R.
    Lenz, Heinz-Josef
    BRITISH JOURNAL OF CANCER, 2022, 126 (01) : 72 - 78
  • [39] Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan
    Vincenzi, Bruno
    Santini, Daniele
    Russo, Antonio
    Gavasci, Michele
    Battistoni, Fabrizio
    Dicuonzo, Giordano
    Rocci, Laura
    Rosaria, Valerio Maria
    Gebbia, Nicola
    Tonini, Giuseppe
    PHARMACOGENOMICS, 2007, 8 (04) : 319 - 327
  • [40] MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
    Kiss, I.
    Mlcochova, J.
    Souckova, K.
    Fabian, P.
    Poprach, A.
    Halamkova, J.
    Svoboda, M.
    Vyzula, R.
    Slaby, O.
    ONCOLOGY LETTERS, 2017, 14 (01) : 743 - 750
12345